Gargoyle Investment Advisor’s Gilead Sciences GILD Stock Holding History

Gargoyle Investment Advisor’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,150	Closed	-$938K	–	122
2018 Q3	$938K	Buy	12,150 +5,911	+95%	+$446K	0.67%	64
2018 Q2	$442K	Sell	6,239 -2,352	-27%	-$166K	0.25%	84
2018 Q1	$648K	Buy	8,591 +1,552	+22%	+$123K	0.27%	84
2017 Q4	$504K	Sell	7,039 -5,455	-44%	-$414K	0.2%	114
2017 Q3	$1.01M	Buy	12,494 +3,401	+37%	+$260K	0.37%	84
2017 Q2	$644K	Hold	9,093	–	–	0.25%	106
2017 Q1	$617K	Hold	9,093	–	–	0.24%	109
2016 Q4	$651K	Sell	9,093 -2,926	-24%	-$217K	0.25%	106
2016 Q3	$951K	Sell	12,019 -2,461	-17%	-$200K	0.36%	97
2016 Q2	$1.21M	Hold	14,480	–	–	0.45%	82
2016 Q1	$1.33M	Hold	14,480	–	–	0.45%	93
2015 Q4	$1.47M	Sell	14,480 -454	-3%	-$47.2K	0.6%	74
2015 Q3	$1.47M	Buy	14,934 +5,434	+57%	+$604K	0.6%	80
2015 Q2	$1.11M	Hold	9,500	–	–	0.42%	83
2015 Q1	$932K	Hold	9,500	–	–	0.35%	90
2014 Q4	$895K	Buy	+9,500	New	+$983K	0.33%	83

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gargoyle Investment Advisor's GILD Position: Q4 2018 in Review

Gargoyle Investment Advisor sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 12,150 shares — an estimated $938K sold.

Gargoyle Investment Advisor first reported a position in GILD in Q4 2014 and held it in 16 quarters. The position peaked at $1.47M in Q3 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Gargoyle Investment Advisor reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Gargoyle Investment Advisor sold 12,150 Gilead Sciences shares in Q4 2018, an estimated $938K.
Gargoyle Investment Advisor first reported a position in Gilead Sciences in Q4 2014 and held it in 16 quarters.
Gargoyle Investment Advisor's Gilead Sciences position peaked at $1.47M in Q3 2015.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2018, filed 14 Feb 2019.